Abstracts-highlighting-updates

Abstracts Highlight Racial Disparities in Gout Prevalence, ED Visits, and Hospitalizations

Abstracts presented at EULAR 2022 focused on racial differences in gout prevalence and treatment, highlighting racial disparities in recent decades. Two abstracts presented at EULAR 2022 identified ... read more

New Poster Track at JADPRO Live Announced: APSHO Patient/Advocacy Perspective

The Advanced Practitioner Society for Hematology and Oncology (APSHO) is pleased to invite oncology advocacy groups and patients to submit abstracts highlighting the unique patient perspective at ... read more

Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis

SAN FRANCISCO, June 08, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that three abstracts highlighting data from its hepatitis B virus (HBV) program have been ... read more

HTG Technology Featured in Multiple Scientific Abstracts Highlighting Novel Applications in Precision Medicine at ASCO 2022

Abstracts were presented by HTG’s key biopharma customers and scientific collaborators from both the United States and Europe highlighting the unique features, benefits and results utilizing HTG ... read more

Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B Data Accepted for ...

SAN FRANCISCO, June 08, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that three abstracts highlighting data from its hepatitis B virus (HBV) program have been ... read more

Why did the Race Oncology share price rocket 10% today?

The Race Oncology Ltd (ASX: RAC) share price flew higher today following a positive announcement by the company. Here are the details. read more

Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B Data Accepted for Presentation at the International Liver Congress™ 2022

SAN FRANCISCO, June 08, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. VIR today announced that three abstracts highlighting data from its hepatitis B virus (HBV) program have been accepted for ... read more

Immuneering Reports Data in Two Preclinical Abstracts at the ASCO 2022 Annual Meeting Highlighting Pan-KRAS/NRAS Activity of IMM-1-104

today reported data in two preclinical abstracts at the 2022 ASCO Annual Meeting highlighting the pan-KRAS/NRAS activity of IMM-1-104. “These data underscore IMM-1-104's potential to broadly target ... read more

HTG Technology Featured in Multiple Scientific Abstracts Highlighting Novel Applications in Precision Medicine at ASCO 2022

Abstracts were presented by HTG’s key biopharma customers and scientific collaborators from both the United States and Europe highlighting the unique features, benefits and results utilizing HTG’s ... read more

Immuneering Reports Data in Two Preclinical Abstracts at the ASCO 2022 Annual Meeting Highlighting Pan-KRAS/NRAS Activity of IMM-1-104

today reported data in two preclinical abstracts at the 2022 ASCO Annual Meeting highlighting the pan-KRAS/NRAS activity of IMM-1-104. “These data underscore IMM-1-104's potential to broadly ... read more